Houston TX 心血管疾病临床试验
24项针对 心血管疾病的研究正在 Houston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
招募中2 期
- Cardiovascular Specialists of Willowbrook, Houston
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Victorium Clinical Research, Houston
- Houston Research Institute, Houston
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
招募中4 期
- Vital Heart and Vein, Humble · 距离 17 英里
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
招募中3 期
- Clinical Trial Site, Houston
- Clinical Trial Site, Houston
- Clinical Trial Site, Houston
- 以及另外 7 项
Zenith® Fenestrated+ Clinical Study
招募中
- Memorial Hermann Texas Medical Center/UT Health, Houston
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
招募中
- CHI Saint Luke's Health-Baylor Saint Luke's Medical Center, Houston
- Houston Methodist Hospital, Houston
- The University of Texas Health Science Center at Houston, Houston
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
招募中
- Houston Methodist Hospital, Houston
- Memorial Hermann-Texas Medical Center, Houston
- Texas Heart Institute at Baylor St. Luke's Medical Center, Houston
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
招募中3 期
- Baylor College Of Medicine, Houston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
招募中2 期
- Clinical Research Site, Houston
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
招募中4 期欢迎健康志愿者
- University of Texas at Houston, Houston
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
招募中观察性研究
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
招募中3 期
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- 以及另外 4 项
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
招募中3 期
- East Texas Cardiology PA, Houston
- Baylor College of Medicine, Houston
- Cardiovascular Specialists of Willowbrook, Houston
- 以及另外 1 项
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
招募中3 期
- Kelsey Seybold Research Foundation, Houston
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
招募中
- Baylor/Texas Heart, Houston
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
招募中
- CHI St. Luke's Health Baylor College of Medicine Medical Center, Houston
- Houston Methodist, Houston
- UTHealth Memorial Hermann, Houston
Pivotal Study for the Cardiac Performance System (CPS)
招募中观察性研究
- Baylor College of Medicine, Houston
DeBakey Cardiovascular Magnetic Resonance Study
招募中观察性研究欢迎健康志愿者
- Houston Methodist Hospital, Houston
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
招募中3 期
- Vital Heart and Vein, Humble · 距离 17 英里
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
招募中
- Houston Healthcare Medical Center, Houston
Randomized Trial of SGLT2i in Heart Transplant Recipients
招募中4 期
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
招募中2 期
- UT Health Houston, Houston
PARTNER 3 Trial - Aortic Valve-in-Valve
招募中
- The University of Texas Health Science Center at Houston, Houston
其他城市的 心血管疾病试验
- Boston, MA37 项研究
- New York City, NY33 项研究
- Washington, DC29 项研究
- Dallas, TX23 项研究
- Atlanta, GA22 项研究
- Cleveland, OH22 项研究
- Chicago, IL21 项研究
- Philadelphia, PA21 项研究
- Pittsburgh, PA20 项研究
- St. Louis, MO20 项研究
- San Francisco, CA18 项研究
- Nashville, TN18 项研究
Houston的其他研究
- 非小细胞肺癌145 项研究
- 乳腺癌126 项研究
- 癌症（所有类型）121 项研究
- 转移性癌症104 项研究
- 结直肠癌102 项研究
- 卵巢癌89 项研究
- 急性髓系白血病85 项研究
- 肺癌78 项研究
- 前列腺癌76 项研究
- 子宫内膜癌68 项研究
- 胰腺癌61 项研究
- 黑色素瘤59 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。